FDA: Innovative Clinical Trials Are Great but Talk to Us First

September 25, 2019

The Food and Drug Administration (FDA) took another step in encouraging drugmakers to pursue innovative ways of testing their investigational medicines, marking a shift away from what the acting head described as a “clunky” clinical trials process.